Administrative Supplement-Signaling by the EGF Receptor from Endosomes
Project Number3R01GM124186-04S1
Former Number5R01GM124186-04
Contact PI/Project LeaderSORKIN, ALEXANDER D
Awardee OrganizationUNIVERSITY OF PITTSBURGH AT PITTSBURGH
Description
Abstract Text
Abstract of Parental Grant GM124186
Elucidation of the mechanisms by which endocytic trafficking regulates signal transduction processes
remains to be profoundly important for understanding how diverse stimuli propagate signals from the cell surface
through the conserved cytosolic machinery and to the nucleus leading to a stimulus- and context-specific
signaling outcome. Epidermal growth factor (EGF) receptor (EGFR), a prototypic receptor tyrosine kinase, has
been the major experimental model to study spatiotemporal regulation of signaling networks. EGFR plays an
essential role in mammalian development and tissue homeostasis in the adult, and is involved in human
pathogenesis, in particular, cancer. However, while the main constituents of the EGFR signaling network are
known, how they coordinately function during EGFR endocytosis and subsequent targeting of receptors for
degradation to endosomes to ensure proper intensity and duration of signaling processes is for the large part
unknown.
Addressing this fundamental question has now become possible owing to the availability of new cutting-
edge methodologies. Using time-resolved quantitative mass-spectrometry of cellular phosphoproteomes we
found that after the majority of active EGFRs are internalized into endosomes, phosphorylation of a multitude of
proteins, known to be involved in the regulation of signaling to growth, survival, cell motility and adhesion, is
maintained by EGFR. Therefore, we hypothesize that the pathways involving these putative signaling effectors
of EGFR operate in endosomes through the sustained activity of endosomal EGFR. We further hypothesize that
by maintaining the activity along some signaling pathways while down-regulating other pathways, EGFR
endocytosis shapes the overall functional outcome of EGFR signaling.
To test these hypothesis in the physiological experimental system (cells that are growth-dependent on
EGFR) we will: 1) examine whether putative substrates and signaling effectors of endocytosed EGFR identified
by the phosphoproteomic analysis are located in EGFR-containing endosomes by labeling endogenous effectors
with fluorescent proteins by gene-editing and dissecting their time-dependent localization dynamics using multi-
dimensional fluorescence microscopy imaging; and 2) examine whether endocytosis and localization in
endosomes control downstream signaling activity of putative phosphorylation substrates and effectors of
endosomal EGFR, and define the mechanisms of this regulation. Combination of the high-throughput method of
labeling endogenous proteins by gene-editing with various methods of quantitative live-cell optical imaging at all
levels of resolution will allow us to apply a systems biology approach to untangling the entire endosomal signaling
program.
Public Health Relevance Statement
The Administrative supplement is requested to enable super-resolution capabilities of the confocal imaging
system to study the epidermal growth factor receptor (EGFR) signaling. EGFR plays important roles in
mammalian development, wound healing, tissue regeneration and tissue homeostasis in the adult. EGFR is
also involved in various cell abnormalities, most notably, tumorigenesis and metastatic processes. The
mechanisms regulating EGFR signaling are incompletely understood. The proposed research will address the
fundamental question of how multiple intertwining signaling pathways activated by EGFR are regulated by the
subcellular localization of the constituents of those pathways.
No Sub Projects information available for 3R01GM124186-04S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3R01GM124186-04S1
Patents
No Patents information available for 3R01GM124186-04S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3R01GM124186-04S1
Clinical Studies
No Clinical Studies information available for 3R01GM124186-04S1
News and More
Related News Releases
No news release information available for 3R01GM124186-04S1
History
No Historical information available for 3R01GM124186-04S1
Similar Projects
No Similar Projects information available for 3R01GM124186-04S1